Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)
Clinical trial NCT05033145 · COMPLETED
Trial details
- NCT number
- NCT05033145
- Sponsor
- HRH Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-15
- Primary completion
- 2022-07-27
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.